Key Takeaways
- SG Power Limited has signed a distribution agreement with Lablink Enterprises.
- The deal involves the sale of hospital products manufactured by Japan’s Nipro Corporation.
- Lablink Enterprises, a long-time distributor of Nipro products, will collaborate with SG Power.
SG Power Limited has entered into a strategic partnership to expand its presence in Pakistan's healthcare sector. The company has signed a distribution agreement with Lablink Enterprises, which will handle the sale and distribution of hospital products manufactured by Japan’s Nipro Corporation across Pakistan.
According to a material information notice submitted to the Pakistan Stock Exchange (PSX), this collaboration is part of SG Power’s broader strategy to strengthen its foothold in the Pakistani market. Lablink Enterprises, known for its 15-year history as the sole distributor of Nipro hospital products in Pakistan, will now work alongside SG Power to ensure a wider reach and better service.
Nipro Corporation, headquartered in Osaka, Japan, is a leading manufacturer of medical devices, pharmaceutical products, hospital infusion therapy products, vascular products, and pharmaceutical packaging. The company operates in over 150 countries, underscoring its global reputation and expertise in the healthcare industry.
SG Power’s decision to partner with Lablink Enterprises reflects its commitment to enhancing access to high-quality medical equipment and services in Pakistan. The agreement is expected to benefit both companies by leveraging their combined strengths and resources. SG Power will continue to provide updates as required under applicable regulatory requirements, ensuring transparency and accountability.
The partnership between SG Power and Nipro Corporation through Lablink Enterprises is anticipated to bring advanced medical technologies and products to Pakistani hospitals and healthcare facilities, thereby improving patient care and treatment options.
